Sample | Title | Value | Rank |
GSM52504 | SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2(sample 1) | 97.6 | 67 |
GSM52508 | SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2(sample 2) | 83.5 | 65 |
GSM52518 | SK-MEL-2 cells treated with Ad-LacZ at MOI 2 plus doxorubicin (sample 1) | 86.7 | 65 |
GSM52519 | SK-MEL-2 cells treated with Ad-LacZ at MOI 2 plus doxorubicin (sample 2) | 107.8 | 69 |
GSM52516 | SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2 plus doxorubicin (sample 1) | 112.3 | 70 |
GSM52517 | SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2 plus doxorubicin (sample 2) | 104.1 | 69 |